Company intelligence / Profile preview
Trigone Pharma
Israeltrigonepharma.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Trigone Pharma is developing a proprietary localized drug delivery platform that enables sustained release of therapeutics directly into the urinary bladder. Its lead product TRG‑100 is in Phase 2 trials for interstitial cystitis/bladder pain syndrome. The company also has preclinical programs targeting overactive bladder and various forms of bladder cancer. Early results suggest improved local efficacy due to prolonged dwell time compared to standard instillation therapies[1][2][3].
- Therapeutic areas
- OncologyNephrologyUrology
- Modalities
- Small moleculesMonoclonal antibodies (via partnership)Combination drugs for intravesical (bladder) delivery[4][5][6]
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Collaboration with 4C Biomed to develop novel immunotherapies for high-grade non-muscle invasive bladder cancer using anti-HVEM monoclonal antibody delivered via Trigone’s technology[5][6].
Beyond the preview
Go deeper on Trigone Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Trigone Pharma.